Tanvex BioPharma USA, Inc.
Quick facts
Marketed products
- NYPOZI · Other
G-CSF binds to specific receptors on hematopoietic cells, stimulating neutrophil production and function.
Phase 3 pipeline
- TX05 (trastuzumab) · Oncology
Trastuzumab is a monoclonal antibody that binds to HER2 receptors on cancer cells, blocking growth signals and triggering immune-mediated cell death.
Competitive intelligence
For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors: